Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr has removed all 17 members of the CDC's Advisory Committee on ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...

Asked where AI is having the biggest impact in digital engagement, around half (49%) of respondents said it was in data ...

Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...

NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

AbbVie presented new data from its novel antibody-drug conjugates (ADCs) at ASCO 2025, including telisotuzumab adizutecan ...

It is the first fundraising effort at Neuralink since its $280 million Series D round in 2023 and brings the company's total ...

The NHS is reported to be in line for a £30 billion ($40.7 billion) increase to its budget in the UK government's upcoming ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

Going into 2025, we expect pharma brands and their advertising partners to use past learnings – and, more importantly – ...